Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2023 annual report, the company carries out wholesale trade in pharmaceutical goods.
| Line item | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|
| Total Revenue | 3,024 | 2,305 | 193 | -74.7% |
| Total COGS | 2,347 | 1,773 | 149 | -74.8% |
| Gross Profit | 677 | 532 | 44 | -74.4% |
| Gross Margin | 22.4% | 23.1% | 23.0% | |
| 89 | 169 | 183 | +43.1% | |
| EBITDA | 588 | 363 | 138 | nmf |
| EBITDA Margin | 19.4% | 15.7% | 71.5% | |
| Total D&A | 1 | 0 | 0 | |
| EBIT / Operating Income | 586 | 363 | 138 | nmf |
| Total Interest Expense | 13 | 10 | 4 | -47.5% |
| Total Other Income | 5 | 1 | 0 | -67.4% |
| Profit Before Tax | 578 | 354 | 141 | nmf |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | 578 | 354 | 141 | nmf |
| Net Margin | 19.1% | 15.4% | 73.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.